MASSIVE is a partner on a Medical Research Future Fund (MRFF) Frontiers project which has been awarded $960,000 for intensive research into new 4D diagnostic technology to allow accurate assessment of lung function in patients of all ages including the very sick.
The Australian Lung Health Initiative headed by Professor Andreas Fouras is one of 10 highly promising research projects to be funded under Stage One of the Medical Research Future Fund (MRFF) Frontiers initiative. The project aims to deliver an original technology that is rapid, easy to use and safe, with less than 10 per cent of the radiation used by X-rays. Patients would not have to remain still or follow instructions, making it suitable for infants, children, older people and the very sick who are difficult to assess with current technology.
The five-year project will build on Australian company 4Dx Limited’s patented XV Technology™, a four-dimensional lung function imaging analysis, and new lose-dose imaging science. Professor Fouras is founder, chairman, and chief executive of 4Dx.
See here for the full announcement here.
Please see here for a 2015 article we wrote on 4DX and their use of MASSIVE.